Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
Authors: Alessandro Mantovani, Christopher D Byrne, Giovanni Targher
Published: 2022-01-12
DOI:
10.1016/s2468-1253(21)00261-2
Source:
Full article
Abstract
No abstract found.